A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck

被引：0
|
作者：
Taylor, Matthew H. [1 ]
Rasco, Drew W. [2 ]
Brose, Marcia S. [3 ]
Vogelzang, Nicholas J. [4 ]
Richey, Stephen L. [4 ]
Cohen, Allen L. [4 ]
Richards, Donald A. [4 ]
Stepan, Daniel E. [5 ]
Dutcus, Corina E. [5 ]
Guo, Matthew [5 ]
Shumaker, Robert C. [5 ]
Schmidt, Emmett V. [6 ]
Young, Louise [7 ]
Wirth, Lori J. [8 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[2] South Texas Accelerated Res Therapeut, San Antonio, TX USA
[3] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[4] McKesson Specialty Hlth, US Oncol Network, Ft Worth, TX USA
[5] Eisai Inc, Woodcliff Lake, NJ USA
[6] Merck & Co Inc, Kenilworth, NJ USA
[7] Eisai Australia Pty Ltd, Melbourne, Vic, Australia
[8] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
366
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [1] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck.
    Taylor, Matthew H.
    Rasco, Drew W.
    Brose, Marcia S.
    Vogelzang, Nicholas J.
    Richey, Stephen Lane
    Cohn, Allen Lee
    Richards, Donald A.
    Stepan, Daniel E.
    Dutcus, Corina E.
    Guo, Matthew
    Shumaker, Robert Charles
    Schmidt, Emmett V.
    Wirth, Lori J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma
    Lee, C-H.
    Makker, V.
    Rasco, D.
    Taylor, M.
    Dutcus, C.
    Shumaker, R.
    Schmidt, E. V.
    Stepan, D.
    Li, D.
    Motzer, R. J.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] A phase 1b trial of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma
    Ikeda, Masafumi
    Sung, Max W.
    Kudo, Masatoshi
    Kobayashi, Masahiro
    Baron, Ari D.
    Finn, Richard S.
    Kaneko, Shuichi
    Zhu, Andrew X.
    Kubota, Tomoki
    Kraljevic, Silvija
    Ishikawa, Kohei
    Siegel, Abby B.
    Kumada, Hiromitsu
    Young, Louise
    Okusaka, Takuji
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 105 - 105
  • [4] A Phase 1b trial of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma
    Ikeda, M.
    Sung, M. W.
    Kudo, M.
    Kobayashi, M.
    Baron, A. D.
    Finn, R. S.
    Kaneko, S.
    Zhu, A. X.
    Kubota, T.
    Kraljevic, S.
    Ishikawa, K.
    Siegel, A. B.
    Kumada, H.
    Okusaka, T.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 37 - 37
  • [5] A phase 1b study of lenvatinib plus pembrolizumab in unresectable hepatocellular carcinoma
    Finn, Richard
    Ikeda, Masafumi
    Zhu, Andrew
    Sung, Max W.
    Baron, Ari D.
    Kudo, Masatoshi
    Okusaka, Takuji
    Kobayashi, Masahiro
    Kumada, Hiromitsu
    Kaneko, Shuichi
    Pracht, Marc
    Mamontov, Konstantin
    Meyer, Tim
    Mody, Kalgi
    Kubota, Tomoki
    Dutcus, Corina E.
    Saito, Kenichi
    Siegel, Abby B.
    Dubrovsky, Leonid
    Llovet, Josep M.
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S120 - S121
  • [6] A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients (pts) with unresectable hepatocellular carcinoma (uHCC).
    Ikeda, Masafumi
    Sung, Max W.
    Kudo, Masatoshi
    Kobayashi, Masahiro
    Baron, Ari David
    Finn, Richard S.
    Kaneko, Shuichi
    Zhu, Andrew X.
    Kubota, Tomoki
    Kraljevic, Silvija
    Ishikawa, Kohei
    Siegel, Abby B.
    Kumada, Hiromitsu
    Okusaka, Takuji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients with selected solid tumors
    Taylor, M.
    Dutcus, C. E.
    Schmidt, E.
    Bagulho, T.
    Li, D.
    Shumaker, R.
    Rasco, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [8] A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma
    Yang, Eddy S.
    Deutsch, Eric
    Mehmet, Altan
    Fayette, Jerome
    Tao, Yungan
    Nabell, Lisle
    Spencer, Sharon A.
    Wang, Xuejing A.
    Spoljoric, Elizabeth A.
    Zhang, Wei
    Hynes, Scott M.
    Decker, Rodney L.
    Lin, Aimee K. Bence
    William, William N., Jr.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 157 : 203 - 209
  • [9] Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma
    Matsuo, Mioko
    Masuda, Muneyuki
    Yamauchi, Moriyasu
    Taura, Masahiko
    Hashimoto, Kazuki
    Kogo, Ryunosuke
    Jiromaru, Rina
    Hongo, Takahiro
    Manako, Tomomi
    Nakagawa, Takashi
    [J]. IN VIVO, 2023, 37 (05): : 2188 - 2196
  • [10] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    McDonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    [J]. NATURE MEDICINE, 2023, 29 (04) : 880 - 887
12345